In This Article:
WELL Health Technologies Corp. (TSE:WELL) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's statutory forecasts. The analysts greatly increased their revenue estimates, suggesting a stark improvement in business fundamentals.
Following the upgrade, the latest consensus from WELL Health Technologies' 13 analysts is for revenues of CA$1.4b in 2025, which would reflect a huge 49% improvement in sales compared to the last 12 months. Statutory earnings per share are supposed to decrease 7.2% to CA$0.12 in the same period. Prior to this update, the analysts had been forecasting revenues of CA$1.2b and earnings per share (EPS) of CA$0.069 in 2025. So we can see there's been a pretty clear increase in analyst sentiment in recent times, with both revenues and earnings per share receiving a decent lift in the latest estimates.
View our latest analysis for WELL Health Technologies
Despite these upgrades, the consensus price target fell 6.3% to CA$7.86, perhaps signalling that the uplift in performance is not expected to last.
These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the WELL Health Technologies' past performance and to peers in the same industry. We can infer from the latest estimates that forecasts expect a continuation of WELL Health Technologies'historical trends, as the 49% annualised revenue growth to the end of 2025 is roughly in line with the 49% annual revenue growth over the past five years. Compare this with the broader industry, which analyst estimates (in aggregate) suggest will see revenues grow 12% annually. So although WELL Health Technologies is expected to maintain its revenue growth rate, it's definitely expected to grow faster than the wider industry.
The Bottom Line
The biggest takeaway for us from these new estimates is that analysts upgraded their earnings per share estimates, with improved earnings power expected for this year. Fortunately, analysts also upgraded their revenue estimates, and our data indicates sales are expected to perform better than the wider market. A lower price target is not intuitively what we would expect from a company whose business prospects are improving - at least judging by these forecasts - but if the underlying fundamentals are strong, WELL Health Technologies could be one for the watch list.